Higher versus Lower Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose-Response Meta-analysis.

Tyler PitreJohnny SuJasmine MahWryan HelmecziSharef DanhoeWilliam PlaxtonStephen GiilckBram RochwergDena Zeraatkar

Published in: Annals of the American Thoracic Society (2022)

Relatively higher doses of corticosteroids may be beneficial in patients with severe-to-critical COVID-19 and may not increase the risk of nosocomial infections. .

Keyphrases

coronavirus disease
sars cov
systematic review
early onset
meta analyses
drug induced
cystic fibrosis
klebsiella pneumoniae
drug resistant
multidrug resistant
methicillin resistant staphylococcus aureus